TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.91+0.10 (+5.52%)
Close on Nov 17, 2026Market cap $22.11MP/E –Yield –
TherapeuticsMD revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
TherapeuticsMD's revenue for the twelve months ending Jun 30, 2026 was $3.27M, up 27.8% year over year. For fiscal 2025 it was $3.02M, up 71.6% from the year before. Over ten years it grew -17.3% a year on average. The highest annual figure on record is $69.96M in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.02M | +71.6% |
| FY2024 | Dec 31, 2024 | $1.76M | +35.3% |
| FY2023 | Dec 31, 2023 | $1.30M | -98.1% |
| FY2022 | Dec 31, 2022 | $69.96M | +2619.1% |
| FY2021 | Dec 31, 2021 | $2.57M | -96.0% |
| FY2020 | Dec 31, 2020 | $64.87M | +30.7% |
| FY2019 | Dec 31, 2019 | $49.65M | +208.4% |
| FY2018 | Dec 31, 2018 | $16.10M | -4.0% |
| FY2017 | Dec 31, 2017 | $16.78M | -13.3% |
| FY2016 | Dec 31, 2016 | $19.36M | -3.9% |
| FY2015 | Dec 31, 2015 | $20.14M | +34.1% |
| FY2014 | Dec 31, 2014 | $15.03M | +71.2% |
| FY2013 | Dec 31, 2013 | $8.78M | +129.8% |
| FY2012 | Dec 31, 2012 | $3.82M | +82.8% |
| FY2011 | Dec 31, 2011 | $2.09M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $869.00K | -8.7% |
| Q1 FY2026 | Mar 31, 2026 | $724.00K | +84.2% |
| Q4 FY2025 | Dec 31, 2025 | $893.00K | +33.9% |
| Q3 FY2025 | Sep 30, 2025 | $784.00K | +43.3% |
| Q2 FY2025 | Jun 30, 2025 | $952.00K | +306.8% |
| Q1 FY2025 | Mar 31, 2025 | $393.00K | +25.6% |
| Q4 FY2024 | Dec 31, 2024 | $667.00K | +32.9% |
| Q3 FY2024 | Sep 30, 2024 | $547.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $234.00K | -46.5% |
| Q1 FY2024 | Mar 31, 2024 | $313.00K | -24.8% |
| Q4 FY2023 | Dec 31, 2023 | $502.00K | -99.3% |
| Q3 FY2023 | Sep 30, 2023 | -$53.00K | -115.0% |
| Q2 FY2023 | Jun 30, 2023 | $437.00K | +25.6% |
| Q1 FY2023 | Mar 31, 2023 | $416.00K | -40.1% |
| Q4 FY2022 | Dec 31, 2022 | $68.57M | +267.1% |
| Q3 FY2022 | Sep 30, 2022 | $354.00K | -98.6% |
| Q2 FY2022 | Jun 30, 2022 | $348.00K | -98.5% |
| Q1 FY2022 | Mar 31, 2022 | $695.00K | -96.5% |
| Q4 FY2021 | Dec 31, 2021 | $18.68M | -17.3% |
| Q3 FY2021 | Sep 30, 2021 | $25.41M | +31.4% |
| Q2 FY2021 | Jun 30, 2021 | $23.00M | +114.9% |
| Q1 FY2021 | Mar 31, 2021 | $19.87M | +62.2% |
| Q4 FY2020 | Dec 31, 2020 | $22.58M | +42.0% |
| Q3 FY2020 | Sep 30, 2020 | $19.34M | -18.5% |
| Q2 FY2020 | Jun 30, 2020 | $10.70M | +76.0% |
| Q1 FY2020 | Mar 31, 2020 | $12.25M | +210.4% |
| Q4 FY2019 | Dec 31, 2019 | $15.90M | +212.5% |
| Q3 FY2019 | Sep 30, 2019 | $23.72M | +582.8% |
| Q2 FY2019 | Jun 30, 2019 | $6.08M | +61.5% |
| Q1 FY2019 | Mar 31, 2019 | $3.95M | +4.6% |
| Q4 FY2018 | Dec 31, 2018 | $5.09M | +23.4% |
| Q3 FY2018 | Sep 30, 2018 | $3.47M | -21.4% |
| Q2 FY2018 | Jun 30, 2018 | $3.76M | -11.5% |
| Q1 FY2018 | Mar 31, 2018 | $3.77M | -5.3% |
| Q4 FY2017 | Dec 31, 2017 | $4.13M | -8.1% |
| Q3 FY2017 | Sep 30, 2017 | $4.42M | -20.2% |
| Q2 FY2017 | Jun 30, 2017 | $4.25M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.99M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.49M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.54M | – |
See a number that looks wrong?